Mead Johnson Nutrition Stock To Go Ex-dividend Tomorrow (MJN)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- The ex-dividend date for Mead Johnson Nutrition Company (NYSE: MJN) is tomorrow, June 20, 2013. Owners of shares as of market close today will be eligible for a dividend of 34 cents per share. At a price of $83.15 as of 9:31 a.m. ET, the dividend yield is 1.6%.

The average volume for Mead Johnson Nutrition has been 1.4 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $16.81 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 26.3% year to date as of the close of trading on Tuesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The company has a P/E ratio of 27.6, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins, good cash flow from operations, growth in earnings per share and revenue growth. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Mead Johnson Nutrition Ratings Report.

See our dividend calendar or top-yielding stocks list.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

McCormick in $4.2 Billion Play for Reckitt Benckiser's Food Division

Reckitt Wrecked By Petya Virus

Reckitt Benckiser Says Petya Cyber Attack Will Slam Q2 Revenues

Reckitt to Close $18 Billion Mead Johnson Takeover Deal June 15